CN1122243A - Medicinal powder for eliminating embolism and invigorating blood circulation - Google Patents
Medicinal powder for eliminating embolism and invigorating blood circulation Download PDFInfo
- Publication number
- CN1122243A CN1122243A CN 95109747 CN95109747A CN1122243A CN 1122243 A CN1122243 A CN 1122243A CN 95109747 CN95109747 CN 95109747 CN 95109747 A CN95109747 A CN 95109747A CN 1122243 A CN1122243 A CN 1122243A
- Authority
- CN
- China
- Prior art keywords
- radix
- ramulus
- blood circulation
- invigorating blood
- medicinal powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The said gangrene-curing medicine powder is a Chinese medicinal mixture. The recipe for early-stage gangrene consists of angelica, monkshood, ginger, peach kernel, Asarum Sieboldii and other Chinese medicinal components, and the recipe for middle- and late-stage gangrene consists of peach kernel, angelica, honeysuckle, Achyranthes bidentata and other Chinese medicinal components. The said medicine can cure gangrene radically.
Description
Medicinal powder for eliminating embolism and invigorating blood circulation provided by the invention relates to the medicine of a kind of treatment necrosis (the inaccessible type vasculitis of thrombosis), is a kind of herb mixture.
Necrosis also claims thrombosis inaccessible type vasculitis, is a kind of difficult and complicated illness.This disease is mainly in human body limb, and the lighter can make and suffer from numb cold of limb, causes amyotrophy, limbs are twitched, are walked lamely, and suffer from the blue dead color of limb mid-term, and pain unbearably, develop into the later stage, suffer from the then burned black necrosis of limb, the dense water of stream festers, meat rots the muscle corruption, refers to that (toe) comes off, and General Symptoms occurs, even cause amputation to disable, the patient suffering can't bear, and does not still have this sick medicine of comparatively ideal treatment on the medical market at present, and the medicine that is generally used for treating necrosis has:
1. low molecular dextran: after having small number of patients to take, skin allergies such as skin pruritus, urticaria, red pimple can appear, the asthma outbreak can appear in the patient who has, individual patient also can be suffered a shock, consumption is excessive cause hemorrhage, as epistaxis gingival hemorrhage, mucocutaneous hemorrhage etc., so congestive heart failure and the patient forbidding of hemorrhage is arranged, the careful usefulness of liver-kidney diseases patient.
2. papaverine hydrochloride: take and to cause diseases such as nauseating, drowsiness, headache, constipation, excessively cause untoward reaction such as atrioventricular block, ventricular fibrillation, obey addiction for a long time.
3. prednisone: belong to hormone medicine, take for a long time and can cause obesity, hirsutism, blood glucose increases, hypertension, intraocular pressure raises, retention of sodium and water, edema, gastric and duodenal ulcers, very person's perforation, osteoporosis, poor wound healing etc.
4. dolantin, morphine: be used for this sick good analgesic effect, but do not cure the disease, and easy addiction.
As from the foregoing, the medicine that is used for the treatment of necrosis at present mostly is to control table, slow curative effect, the development of more difficult disease controlling and deterioration, and toxic side effect, even addiction, when PD to late period, almost past medical help, can only high amputation cause to become heavy residual, cause huge misery mentally with on the health for the patient, bring huge burden economically.
The objective of the invention is to overcome many defectives of treatment necrosis medicine on the existing medical market, provide a kind of curative effect fast, short treating period, have no side effect, the development of disease controlling and deterioration quickly and effectively, and can effect a radical cure this disease, do not stay sequela, never the herb mixture of advantage such as recurrence.
The medicinal powder for eliminating embolism and invigorating blood circulation of treatment necrosis provided by the invention (the inaccessible type vasculitis of thrombosis) belongs to a kind of herb mixture, is made up of the plurality of Chinese composition.Because necrosis disease can divide for three phases, i.e. initial stage, mid-term and late period.According to the residing state of an illness of necrosis disease patient, pathology, the medication of suiting the medicine to the illness, this medicinal powder for eliminating embolism and invigorating blood circulation is divided into two kinds of dosage forms, be applicable to respectively initial stage necrosis patient and in, late period the necrosis patient.Following sample is carefully narrated it:
The contained Chinese medicinal ingredients of medicinal powder for eliminating embolism and invigorating blood circulation that is applicable to initial stage necrosis patient comprises: Radix Angelicae Sinensis, Radix Aconiti Lateralis Preparata, Rhizoma Zingiberis, Semen Persicae, Herba Asari, Cortex Cinnamomi, Flos Carthami, Radix Notoginseng, Ramulus et Folium Bischofiae Javanicae, Radix Astragali, Ramulus Cinnamomi, Caulis Spatholobi, Rhizoma Chuanxiong, Hirudo, eupolyphage sece steleophaga, Folium Artemisiae Argyi, Radix Achyranthis Bidentatae, Radix Rehmanniae Preparata, Squama Manis etc.Its Chinese medicinal ingredients weight proportion is as follows:
Radix Angelicae Sinensis 10-25g Semen Persicae 10-20g
Flos Carthami 5-20g Radix Notoginseng 5-15g
Ramulus et Folium Bischofiae Javanicae 5-20g Radix Aconiti Lateralis Preparata 5-20g
Rhizoma Zingiberis 5-20g Herba Asari 5-10g
Cortex Cinnamomi 5-20g Radix Astragali 20-70g
Ramulus Cinnamomi 10-20g Radix Rehmanniae Preparata 5-25g
Caulis Spatholobi 10-50g Rhizoma Chuanxiong 10-20g
Hirudo 5-15g eupolyphage sece steleophaga 5-15g
Folium Artemisiae Argyi 5-25g Radix Achyranthis Bidentatae 10-20g
Squama Manis 5-15g
In being applicable to, late period the necrosis patient the contained Chinese medicinal ingredients of medicinal powder for eliminating embolism and invigorating blood circulation comprise: Semen Persicae, Radix Angelicae Sinensis, Flos Lonicerae, Squama Manis, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Hirudo, Radix Notoginseng, Herba Taraxaci, Radix Salviae Miltiorrhizae, Flos Carthami, Radix Astragali, thermally, Radix Rehmanniae, Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, one meter, Ramulus et Folium Bischofiae Javanicae, Fructus Toosendan, Rhizoma Corydalis, Herba Violae, Olibanum, Myrrha, Radix Glycyrrhizae etc.
Its Chinese medicinal ingredients weight proportion is:
Semen Persicae 10-20g Radix Angelicae Sinensis 20-50g
Flos Lonicerae 20-50g Squama Manis 5-15g
Radix Achyranthis Bidentatae 10-20g Radix Paeoniae Rubra 10-20g
Hirudo 5-15g Radix Notoginseng 5-15g
Herba Taraxaci 15-50g Radix Salviae Miltiorrhizae 10-50g
Flos Carthami 10-15g Radix Astragali 20-70g
Radix Rehmanniae Preparata 10-25g Radix Rehmanniae 10-50g
Radix Aconiti Lateralis Preparata 2-5g Ramulus Cinnamomi 2-5g
One meter 10-50g Ramulus et Folium Bischofiae Javanicae 10-25g
Fructus Toosendan 5-15g Rhizoma Corydalis 10-20g
Herba Violae 15-50g Olibanum 5-15g
Radix Glycyrrhizae 5-20g Myrrha 5-15g
Embodiment 1. medicinal powder for eliminating embolism and invigorating blood circulation dosage form I: treatment initial stage necrosis patient.
The state of an illness and symptom: suffer from limb and send out cold, numb, pallor does not have the pool, and intermittent limping is arranged, the time tic is arranged, muscle is atrophy gradually, fine hair is sparse to come off, refer to (toe) first thicken, coarse and crisp, fall YANG pulse, the Taixi arteries and veins weakens or disappear.
Therapeutic Method: blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian.
Treatment prescription and weight proportion:
Radix Astragali 20-70g Radix Angelicae Sinensis 10-25g
Ramulus Cinnamomi 10-20g Radix Aconiti Lateralis Preparata 5-20g
Rhizoma Zingiberis 5-20g Caulis Spatholobi 10-50g
Semen Persicae 10-20g Herba Asari 5-10g
Rhizoma Chuanxiong 10-20g Cortex Cinnamomi 5-20g
Flos Carthami 5-20g Hirudo 5-15g
Radix Notoginseng 5-15g eupolyphage sece steleophaga 5-15g
Folium Artemisiae Argyi 5-25g Radix Achyranthis Bidentatae 10-20g
Radix Rehmanniae Preparata 5-25g Squama Manis 5-15g
Ramulus et Folium Bischofiae Javanicae 5-20g
This prescription is treated necrosis initial stage patient 578 examples through the 1988-1995 clinic trial, and wherein 549 routine patients obtain recovery from illness, and 29 routine patients obtain and are clearly better, and cure rate reaches more than 95%, effective percentage 100%.
Embodiment 2. medicinal powder for eliminating embolism and invigorating blood circulation dosage form II: in the treatment, late period the necrosis patient.
The state of an illness and symptom:
Mid-term: suffer from limb pain unbearably, range of activity is limited, and walking pain is unusual, and pain is also arranged when static, the strongly fragrant heat-transformation of a specified duration of cold-evil and cause the blue dead color of local skin, and refer to (toe) to its place's development by one, and conscious cold, symptom subtracts slightly, but the pain increased, lie awake all night, the food poor appetite, trouble limb muscle is become thin or slight edema more.
Late period: suffer from limb severe pain or causalgia, light night in daytime is heavy, and profile is withered, and very then burned black necrosis is festered, and flows dense water, and meat rot the muscle corruption, refers to that (toe) comes off, and General Symptoms can occur, and the complexion sunshine is dark or pale, and the vexed utmost point is eaten indigestion and loss of appetitely, large and smallly just lacks of proper care.
Therapeutic Method: blood circulation and channel invigorating, nourishing YIN to lower pathogenic fire and battalion's detoxifcation.
Treatment prescription and weight proportion:
Radix Salviae Miltiorrhizae 10-50g Semen Persicae 10-20g
Flos Carthami 10-15g Radix Astragali 20-70g
Radix Angelicae Sinensis 20-50g Radix Rehmanniae Preparata 10-25g
Flos Lonicerae 20-50g Squama Manis 5-15g
Radix Rehmanniae 10-50g Radix Aconiti Lateralis Preparata 2-5g
Ramulus Cinnamomi 2-5g Radix Achyranthis Bidentatae 10-20g
One meter 10-50g Ramulus et Folium Bischofiae Javanicae 10-25g
Radix Paeoniae Rubra 10-20g Hirudo 5-15g
Radix Notoginseng 5-15g Fructus Toosendan 5-15g
Rhizoma Corydalis 10-20g Herba Taraxaci 15-50g
Herba Violae 15-50g Olibanum 5-15g
Myrrha 5-15g Radix Glycyrrhizae 5-20g
This prescription is treated necrosis patient 425 examples in mid-term through the 1988-1995 clinic trial, and wherein 414 routine patients obtain recovery from illness, 11 routine patients are clearly better, cure rate reaches more than 95%, effective percentage 100%, treatment necrosis patient 316 examples in late period, wherein 284 routine patients obtain recovery from illness, 22 routine patients are taken a favorable turn, and cure rate reaches more than 90%, effective percentage 100%, 47 days of short treating period, long 124 days of the course of treatment.
Claims (4)
1. treat necrosis new drug medicinal powder for eliminating embolism and invigorating blood circulation for one kind, it is characterized in that being a kind of herb mixture, be made up of the plurality of Chinese composition, its Chinese medicinal ingredients comprises Radix Angelicae Sinensis, Radix Aconiti Lateralis Preparata, Rhizoma Zingiberis, Semen Persicae, Herba Asari, Cortex Cinnamomi, Flos Carthami, Radix Notoginseng, Ramulus et Folium Bischofiae Javanicae, Radix Astragali, Ramulus Cinnamomi, Caulis Spatholobi, Rhizoma Chuanxiong, Hirudo, eupolyphage sece steleophaga, Folium Artemisiae Argyi, Radix Achyranthis Bidentatae, Radix Rehmanniae Preparata, Squama Manis etc.
2. by the described medicinal powder for eliminating embolism and invigorating blood circulation of claim 1, it is characterized in that described Chinese medicinal ingredients weight proportion is as follows:
Radix Angelicae Sinensis 10-25g Semen Persicae 10-20g
Flos Carthami 5-20g Radix Notoginseng 5-15g
Ramulus et Folium Bischofiae Javanicae 5-20g Radix Aconiti Lateralis Preparata 5-20g
Rhizoma Zingiberis 5-20g Herba Asari 5-10g
Cortex Cinnamomi 5-20g Radix Astragali 20-70g
Ramulus Cinnamomi 10-20g Radix Rehmanniae Preparata 5-25g
Caulis Spatholobi 10-50g Rhizoma Chuanxiong 10-20g
Hirudo 5-15g eupolyphage sece steleophaga 5-15g
Folium Artemisiae Argyi 5-25g Radix Achyranthis Bidentatae 10-20g
Squama Manis 5-15g
3. by the described medicinal powder for eliminating embolism and invigorating blood circulation of claim 1, it is characterized in that described Chinese medicinal ingredients can also be: Semen Persicae, Flos Lonicerae, Radix Angelicae Sinensis, Squama Manis, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Hirudo, Radix Notoginseng, Herba Taraxaci, Radix Salviae Miltiorrhizae, Flos Carthami, Radix Astragali, Radix Rehmanniae Preparata, the Radix Rehmanniae, Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, one meter, Ramulus et Folium Bischofiae Javanicae, Fructus Toosendan, Rhizoma Corydalis, Herba Violae, Olibanum, Myrrha, Radix Glycyrrhizae.
4. by the described medicinal powder for eliminating embolism and invigorating blood circulation of claim 3, it is characterized in that the weight proportion of described Chinese medicinal ingredients is as follows:
Semen Persicae 10-20g Radix Angelicae Sinensis 20-50g
Flos Lonicerae 20-50g Squama Manis 5-15g
Radix Achyranthis Bidentatae 10-20g Radix Paeoniae Rubra 10-20g
Hirudo 5-15g Radix Notoginseng 5-15g
Herba Taraxaci 15-50g Radix Salviae Miltiorrhizae 10-50g
Flos Carthami 10-15g Radix Astragali 20-70g
Radix Rehmanniae Preparata 10-25g Radix Rehmanniae 10-50g
Radix Aconiti Lateralis Preparata 2-5g Ramulus Cinnamomi 2-5g
One meter 10-50g Ramulus et Folium Bischofiae Javanicae 10-25g
Fructus Toosendan 5-15g Rhizoma Corydalis 10-20g
Herba Violae 15-50g Olibanum 5-15g
Myrrha 5-15g Radix Glycyrrhizae 5-20g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95109747 CN1122243A (en) | 1995-08-16 | 1995-08-16 | Medicinal powder for eliminating embolism and invigorating blood circulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95109747 CN1122243A (en) | 1995-08-16 | 1995-08-16 | Medicinal powder for eliminating embolism and invigorating blood circulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1122243A true CN1122243A (en) | 1996-05-15 |
Family
ID=5077330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 95109747 Pending CN1122243A (en) | 1995-08-16 | 1995-08-16 | Medicinal powder for eliminating embolism and invigorating blood circulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1122243A (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059103C (en) * | 1996-12-20 | 2000-12-06 | 郎鸿志 | High-effective Naoxinning-medicine for curing cardio-cerebral disease |
| CN100335078C (en) * | 2005-06-10 | 2007-09-05 | 王春记 | Chinese proprietary medicine for treating lumbar disease |
| CN100341545C (en) * | 2005-01-27 | 2007-10-10 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
| CN101450126B (en) * | 2009-01-09 | 2010-12-29 | 黑颖睿 | Formula for treating lower-limb deep veins thrombus |
| CN102302629A (en) * | 2011-07-28 | 2012-01-04 | 刘文章 | Channel warming and collateral dredging medicine wine |
| CN102824608A (en) * | 2012-09-12 | 2012-12-19 | 山东省千佛山医院 | Externally used Chinese herba preparation for treating peripheral vascular disease |
| CN103083638A (en) * | 2013-01-28 | 2013-05-08 | 徐琳 | Medicament for treating osteoporosis |
| CN103285360A (en) * | 2013-06-09 | 2013-09-11 | 王京涛 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof |
| CN103705623A (en) * | 2013-12-18 | 2014-04-09 | 广州市中医医院 | Application of semi-bionic extraction method in eliminating precipitate in liquid traditional Chinese medicinal preparation |
| CN103705665A (en) * | 2012-10-09 | 2014-04-09 | 黑龙江省中医研究院 | Pharmaceutical composition used for treating thromboangiitis obliterans, and preparation method thereof |
| CN104042788A (en) * | 2014-06-19 | 2014-09-17 | 张金龙 | Traditional Chinese medicine composition for treating thromboangitis obliterans |
| CN104055968A (en) * | 2014-07-01 | 2014-09-24 | 王磊 | Aerosol with effects of promoting blood circulation to remove meridian obstruction for postoperative patients |
| CN104288424A (en) * | 2014-11-03 | 2015-01-21 | 韩崇明 | Traditional Chinese materia medica preparation for treating interventional post-operation deep venous thrombosis and preparation method thereof |
| CN104758567A (en) * | 2015-03-26 | 2015-07-08 | 纪建伟 | Traditional Chinese medicine for treating angiitis |
| CN104998021A (en) * | 2015-07-03 | 2015-10-28 | 成都市飞龙水处理技术研究所 | Oral medicine used for treating thromboangiitis obliterans, and preparation method thereof |
| CN105012418A (en) * | 2015-07-01 | 2015-11-04 | 成都市飞龙水处理技术研究所青白江第一分所 | Drug for effective treatment of thromboangiitis obliterans and preparation method thereof |
| CN105079242A (en) * | 2014-05-14 | 2015-11-25 | 李东海 | Medicine for treating thromboangiitis obliterans |
| EP3062807A4 (en) * | 2013-10-28 | 2017-06-14 | Korea Institute of Oriental Medicine | Compositions comprising a viola herba extract, or an extract of viola herba, persicae semen, cinnamomi ramulus, and glycyrrhiza spp. for the prevention or treatment of lipid-related cardiovascular diseases and obesity |
| CN109908217A (en) * | 2019-04-17 | 2019-06-21 | 中国中医科学院广安门医院 | It is a kind of for treating the Chinese medicine composition and application thereof of arterial thrombus obliterans |
| CN115957291A (en) * | 2023-01-10 | 2023-04-14 | 广东飞来生物科技有限公司 | Jiufeng oil for restoring menstrual flow and activating blood circulation and preparation method thereof |
-
1995
- 1995-08-16 CN CN 95109747 patent/CN1122243A/en active Pending
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059103C (en) * | 1996-12-20 | 2000-12-06 | 郎鸿志 | High-effective Naoxinning-medicine for curing cardio-cerebral disease |
| CN100341545C (en) * | 2005-01-27 | 2007-10-10 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
| CN100335078C (en) * | 2005-06-10 | 2007-09-05 | 王春记 | Chinese proprietary medicine for treating lumbar disease |
| CN101450126B (en) * | 2009-01-09 | 2010-12-29 | 黑颖睿 | Formula for treating lower-limb deep veins thrombus |
| CN102302629A (en) * | 2011-07-28 | 2012-01-04 | 刘文章 | Channel warming and collateral dredging medicine wine |
| CN102824608A (en) * | 2012-09-12 | 2012-12-19 | 山东省千佛山医院 | Externally used Chinese herba preparation for treating peripheral vascular disease |
| CN102824608B (en) * | 2012-09-12 | 2014-01-22 | 山东省千佛山医院 | Externally used Chinese herba preparation for treating peripheral vascular disease |
| CN103705665A (en) * | 2012-10-09 | 2014-04-09 | 黑龙江省中医研究院 | Pharmaceutical composition used for treating thromboangiitis obliterans, and preparation method thereof |
| CN103705665B (en) * | 2012-10-09 | 2017-02-22 | 黑龙江省中医研究院 | Pharmaceutical composition used for treating thromboangiitis obliterans, and preparation method thereof |
| CN103083638A (en) * | 2013-01-28 | 2013-05-08 | 徐琳 | Medicament for treating osteoporosis |
| CN103083638B (en) * | 2013-01-28 | 2014-03-05 | 徐琳 | Medicament for treating osteoporosis |
| CN103285360A (en) * | 2013-06-09 | 2013-09-11 | 王京涛 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof |
| EP3062807A4 (en) * | 2013-10-28 | 2017-06-14 | Korea Institute of Oriental Medicine | Compositions comprising a viola herba extract, or an extract of viola herba, persicae semen, cinnamomi ramulus, and glycyrrhiza spp. for the prevention or treatment of lipid-related cardiovascular diseases and obesity |
| CN103705623A (en) * | 2013-12-18 | 2014-04-09 | 广州市中医医院 | Application of semi-bionic extraction method in eliminating precipitate in liquid traditional Chinese medicinal preparation |
| CN103705623B (en) * | 2013-12-18 | 2014-11-05 | 广州市中医医院 | Application of semi-bionic extraction method in eliminating precipitate in liquid traditional Chinese medicinal preparation |
| CN105079242A (en) * | 2014-05-14 | 2015-11-25 | 李东海 | Medicine for treating thromboangiitis obliterans |
| CN104042788A (en) * | 2014-06-19 | 2014-09-17 | 张金龙 | Traditional Chinese medicine composition for treating thromboangitis obliterans |
| CN104042788B (en) * | 2014-06-19 | 2017-07-28 | 杨志丽 | A kind of Chinese medicine composition for treating Buerger's disease |
| CN104055968A (en) * | 2014-07-01 | 2014-09-24 | 王磊 | Aerosol with effects of promoting blood circulation to remove meridian obstruction for postoperative patients |
| CN104288424A (en) * | 2014-11-03 | 2015-01-21 | 韩崇明 | Traditional Chinese materia medica preparation for treating interventional post-operation deep venous thrombosis and preparation method thereof |
| CN104758567A (en) * | 2015-03-26 | 2015-07-08 | 纪建伟 | Traditional Chinese medicine for treating angiitis |
| CN104758567B (en) * | 2015-03-26 | 2018-03-13 | 纪建伟 | A kind of Chinese medicine for treating vasculitis disease |
| CN105012418A (en) * | 2015-07-01 | 2015-11-04 | 成都市飞龙水处理技术研究所青白江第一分所 | Drug for effective treatment of thromboangiitis obliterans and preparation method thereof |
| CN104998021A (en) * | 2015-07-03 | 2015-10-28 | 成都市飞龙水处理技术研究所 | Oral medicine used for treating thromboangiitis obliterans, and preparation method thereof |
| CN109908217A (en) * | 2019-04-17 | 2019-06-21 | 中国中医科学院广安门医院 | It is a kind of for treating the Chinese medicine composition and application thereof of arterial thrombus obliterans |
| CN109908217B (en) * | 2019-04-17 | 2022-03-01 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating lower limb arteriosclerosis obliterans and application thereof |
| CN115957291A (en) * | 2023-01-10 | 2023-04-14 | 广东飞来生物科技有限公司 | Jiufeng oil for restoring menstrual flow and activating blood circulation and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1122243A (en) | Medicinal powder for eliminating embolism and invigorating blood circulation | |
| CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
| CN100548350C (en) | A kind of Chinese medicine for the treatment of thromboangiitis obliterans | |
| CN1060960C (en) | Health-care wine with antisenility function | |
| CN1350852A (en) | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout | |
| CN1095610A (en) | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases | |
| CN1966003A (en) | Externally applied medicament for treating rheumatism | |
| CN1342462A (en) | Composite medicine for treating rheumatoid arthritis | |
| CN1539447A (en) | Medicated rehabilitation wine for treating premonitory apoplexy, sequela of apoplexy and obastrcution of qi in chest | |
| CN1112836A (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN1061884C (en) | Chinese medicine for ischemic necrosis of thighbone head | |
| CN1299723C (en) | Medicine for treating rhomboembolia type angiitis | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1977936A (en) | Chinese medicine compound preparation for treating male-female deficiency syndrome and its preparing method | |
| CN1456180A (en) | Medicine for curing leucoderma and preparing method thereof | |
| CN1788766A (en) | Oral Chinese traditional medicine for treating diabetes foot | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN101129425B (en) | Traditional Chinese medicine for treating zoster | |
| CN1285354C (en) | Medicine for treating cerebral infarction | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1175884C (en) | Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof | |
| CN1128667A (en) | Thrombus-eliminating pills | |
| CN1122242A (en) | Medicinal powder for rheumatoid disease | |
| CN101380425B (en) | Arthrosis pill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |